Ryvu Therapeutics
Develop therapeutics that address clinical limitations of current treatments in oncology. Learn more
Launch date
Employees
Market cap
$315m
Enterprise valuation
$265m (Public information from Sep 2024)
Share price
PLN54.2 RVU.WA
Kraków Lesser Poland Voivodeship (HQ)
Authorizing premium user...